News

press

Oct 31, 2024

Press Release

Shasqi to present at World ADC and SITC conferences

conference

Oct 23, 2024

2024 - EORTC-NCI-AACR Symposium

Pre-Targeting with in vivo Click Chemistry Enables Preferential Drug Exposure in Tumors versus Normal Tissues

conference

Oct 10, 2024

2024 - SITC

Shasqi announces two abstracts accepted for poster presentation at the SITC 39th Annual Meeting, held November 8-10, 2024, in Houston, TX

conference

Oct 10, 2024

2024 - World ADC

Shasqi presenting two sessions at World ADC 2024

event

Aug 30, 2024

Event

Shasqi CEO, José Mejía Oneto, joining panel at LSX USA World Congress on September 11th, Boston

event

Aug 29, 2024

Event

Shasqi VP of Research Travis Biechele, PhD, presenting at ADC & Radiopharmaceuticals Pharma & Biotech Partner summit in Boston on September 9th

conference

Jun 1, 2024

2024 - ASCO

Shasqi presents Phase 2a results of SQ3370 in STS patients at ASCO 2024

conference

Apr 10, 2024

2024 - AACR

Shasqi presented 5 posters at the 2024 American Association for Cancer Research (AACR) Annual Meeting

press

Apr 5, 2024

Press Release

Shasqi to Present Data on Novel Tumor-Targeted Drug Activation Technology at 2024 American Association for Cancer Research (AACR) Annual Meeting

conference

Mar 17, 2024

2024 - ACS

MMAE payload uncoupled from HER2 targeting agent is selectively activated at tumors through click chemistry in vivo

press

Mar 11, 2024

Press Release

Shasqi Appoints Travis Biechele, Ph.D. as VP of Research to Lead Pipeline Development

press

Mar 5, 2024

Press Release

Shasqi to Present New Data at 2024 World ADC London Conference